Clinical Trial Detail

NCT ID NCT02807805
Title Abiraterone Acetate, Niclosamide, and Prednisone in Treating Patients With Hormone-Resistant Prostate Cancer
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors University of California, Davis
Indications

prostate cancer

Therapies

Abiraterone + Niclosamide + Prednisone

Age Groups: adult

No variant requirements are available.